Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

NCT02711137 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

137

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to safety issues.

Conditions

Solid Tumors

Interventions

DRUG: INCB057643
DRUG: Gemcitabine
DRUG: Paclitaxel
DRUG: Rucaparib
DRUG: Abiraterone
DRUG: Ruxolitinib
DRUG: Azacitidine

Sponsor

Incyte Corporation